Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100047183Phase 4Recruiting
Phase 4 trial of duloxetine in adhesive capsulitis (AC) (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Visual analogue scale at 12 weeks. Started Jun 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100047183.